We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
ABOUT US / HISTORY HIGHLIGHTS

HISTORY HIGHLIGHTS

2018
The Group rebrands to Neuraxpharm
2017
Spanish Health Authorities GMP inspection
(4th inspection)
2016
FDA inspection (5th inspection)
Invent Farma Group acquired by funds advised by Apax Partners
2014
Spanish Health Authorities GMP inspection
(3rd inspection)
2012
Korean agency (KFDA) inspection
2008
Spanish Health Authorities GMP inspection
(1st inspection)
2005
Inke acquired by Invent Farma
2002
FDA inspection (1st inspection)
ISO 14001 certification
2000
ISO 9001 certification
Enalapril and Nitrendipine CEP granted
First product sold in Japan (Loratadine)
First specific microniser installed to produce a respiratory product (Formoterol)
1998
Development of first respiratory product (Formoterol)
Beginning of Inke's international expansion
1986
First microniser installed at Inke (Loratadine)
1980
Inke, S.A. is founded
Inke, S.A. is founded